We combined the data acquired for mLama4- and mAlg8-specific TILs from tumour-bearing mice undergoing anti-CTLA-4 treatment together with data acquired from isotype mAb-treated mice to produce an overall map of all observed phenotypic profiles of tumour-specific TILs. This evidence concerns the gene CTLA4 and neoplasm.